Let's Talk About Retirement: Unexpected Costs to Plan For
mehr
Storys zum Thema Health insurance
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
APRIL signs strategic partnership with KKR for its next phase of growth
Paris and Lyon, France (ots/PRNewswire) - After refocusing its activities around insurance distribution and carrying out an in-depth transformation of its business model since its acquisition by CVC Capital Partners in 2019, enabling the group to return to a high level of performance, the APRIL Group announces that it has signed a long-term strategic partnership with ...
mehrHelsana Drug Report: Spitex patients exposed to significant medication risks
Zurich (ots) - In 2019, medication costs in Switzerland totalled approximately CHF 7.6 billion. The front runners remained cancer and immune system drugs, followed by nervous system medications and metabolic preparations. The use of biosimilars (generic preparations) offers significant savings potential that unfortunately remains almost completely unexploited. In an ...
mehrZur Rose and KPT together launch digital medicines assistant Medi+
mehrHelsana posts outstanding result for 2019
Zürich (ots) - In 2019, Helsana Insurance Company Ltd recorded an outstanding result of CHF 436 million. This comprises a very strong investment performance and a solid underwriting result. Customer growth for 2020 once again clearly exceeded the prior year and the new corporate strategy was successfully launched at the start of 2020. In 2019, Helsana Insurance Company Ltd recorded an outstanding result of CHF 436 ...
mehrQuality-related problems concerning the prescription of medication / Helsana Drug Report
Zurich (ots) - The medication costs in Switzerland amounted to about CHF 7.6 billion in 2018. Since 2010, costs have risen by 46 percent, whereby half of this increase was attributable to immunosuppressants and cancer medication. Great savings potential is above all associated with the use of biosimilars. One of the other findings of this year's Helsana Drug Report is ...
mehr
1